[#item_full_content]
Year: 2023
Focal Medical Complete Development of a Therapeutic System to Deliver Gemcitabine Directly to the Pancreas
[#item_full_content]CARY, N.C.–(BUSINESS WIRE)–Focal Medical, Inc., a privately held, biopharmaceutical company developing novel precision therapeutic products today…
Daversa Partners Wins 2023 Public Relations and Marketing Excellence Award
[#item_full_content]NEW YORK–(BUSINESS WIRE)–Today the Business Intelligence Group announced that Daversa Partners has won the 2023 Public…